Salmeterol Xinafoate and Fluticasone Propionate Powder with Montelukast Soudium in Treatment of Pre-school Children Asthma
FU Pei-pe
Abstract
FU Pei-pe
Abstract
Objective:To compare the effectiveness of Salmeterol Fluticasone Powder Inhalant combined with Montelukast and single Salmeterol Fluticasone powder inhalant.Method:80 cases with moderate intermittent asthma in preschool childen(aged 3-5)were randomly divided into two groups. The trial group with Salmeterol Fluticasone powder inhalant 50/100 μg(GlaxoSmithKline Co.)for each 12 h inhalation time,Montelukast 4mg (Hangzhou MSD)morning meal in a suit;the control group only used Salmeterol Fluticasone powder inhalant 50/100 μg(GlaxoSmithKline Co.)for each 12 h inhalation time. The two groups were gargle with warm water after treatment.After treatment,compared lung function and asthma control test score of two groups,and observed adverde reactiond. Result:After 3 months of treatment,the treatment group compared with the control group,in treatment group,PEFR value of the percentage of predicted value compared with the control group improved significantly( P 0.05),the clinical symptoms and the treatment group was significantly better than the control group( P 0.01).Conclusion:Salmeterol inhalation fluticasone and montelukast tablets pre - school children asthma combination therapy is more rapid improvement in clinical symptoms and lung function,can significantly improve the efficacy of the treatment of children with asthma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To compare the effectiveness of Salmeterol Fluticasone Powder Inhalant combined with Montelukast and single Salmeterol Fluticasone powder inhalant.Method:80 cases with moderate intermittent asthma in preschool childen(aged 3-5)were randomly divided into two groups. The trial group with Salmeterol Fluticasone powder inhalant 50/100 μg(GlaxoSmithKline Co.)for each 12 h inhalation time,Montelukast 4mg (Hangzhou MSD)morning meal in a suit;the control group only used Salmeterol Fluticasone powder inhalant 50/100 μg(GlaxoSmithKline Co.)for each 12 h inhalation time. The two groups were gargle with warm water after treatment.After treatment,compared lung function and asthma control test score of two groups,and observed adverde reactiond. Result:After 3 months of treatment,the treatment group compared with the control group,in treatment group,PEFR value of the percentage of predicted value compared with the control group improved significantly( P 0.05),the clinical symptoms and the treatment group was significantly better than the control group( P 0.01).Conclusion:Salmeterol inhalation fluticasone and montelukast tablets pre - school children asthma combination therapy is more rapid improvement in clinical symptoms and lung function,can significantly improve the efficacy of the treatment of children with asthma.
Key concepts: Medicine, Salmeterol, Montelukast, Fluticasone, Fluticasone propionate, Inhalation, Asthma, Anesthesia